187 related articles for article (PubMed ID: 36372916)
1. LncRNAs and MiRNAs: New Targets for Resveratrol in Ovarian Cancer Research.
Chaichian S; Bidgoli SA; Nikfar B; Moazzami B
Curr Med Chem; 2023; 30(28):3238-3248. PubMed ID: 36372916
[TBL] [Abstract][Full Text] [Related]
2. Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer.
Fu LL; Li CJ; Xu Y; Li LY; Zhou X; Li DD; Chen SX; Wang FG; Zhang XY; Zheng LW
Crit Rev Eukaryot Gene Expr; 2017; 27(2):183-195. PubMed ID: 28845767
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA SCAMP1 Targets miR-137/CXCL12 Axis to Boost Cell Invasion and Angiogenesis in Ovarian Cancer.
Song R; Liu Z; Lu L; Liu F; Zhang B
DNA Cell Biol; 2020 Jun; 39(6):1041-1050. PubMed ID: 32401536
[TBL] [Abstract][Full Text] [Related]
5. Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: A comprehensive review.
Asemi R; Rajabpoor Nikoo N; Asemi Z; Shafabakhsh R; Hajijafari M; Sharifi M; Homayoonfal M; Davoodvandi A; Hakamifard A
Pathol Res Pract; 2023 Jun; 246():154507. PubMed ID: 37196467
[TBL] [Abstract][Full Text] [Related]
6. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
[TBL] [Abstract][Full Text] [Related]
7. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
Chang H; Li B; Zhang X; Meng X
Biochem Biophys Res Commun; 2020 Feb; 522(2):292-299. PubMed ID: 31761329
[TBL] [Abstract][Full Text] [Related]
8. LncRNAs in ovarian cancer.
Wang JY; Lu AQ; Chen LJ
Clin Chim Acta; 2019 Mar; 490():17-27. PubMed ID: 30553863
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated expression of long noncoding RNAs in gynecologic cancers.
Hosseini ES; Meryet-Figuiere M; Sabzalipoor H; Kashani HH; Nikzad H; Asemi Z
Mol Cancer; 2017 Jun; 16(1):107. PubMed ID: 28637507
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives.
Bhardwaj V; Tan YQ; Wu MM; Ma L; Zhu T; Lobie PE; Pandey V
Cancer Lett; 2021 Apr; 502():97-107. PubMed ID: 33429007
[TBL] [Abstract][Full Text] [Related]
11. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
[TBL] [Abstract][Full Text] [Related]
12. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches.
Yang C; Kim HS; Song G; Lim W
J Cell Physiol; 2019 Dec; 234(12):21493-21503. PubMed ID: 31144314
[TBL] [Abstract][Full Text] [Related]
13. The pivotal role of long non-coding RNAs as potential biomarkers and modulators of chemoresistance in ovarian cancer (OC).
Malgundkar SH; Tamimi Y
Hum Genet; 2024 Feb; 143(2):107-124. PubMed ID: 38276976
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
Chen XJ; An N
J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
[TBL] [Abstract][Full Text] [Related]
15. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
Panoutsopoulou K; Avgeris M; Scorilas A
Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
[TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the Long Non-Coding RNAs and MicroRNAs Coregulation Networks in Ovarian Cancer Development: An Overview.
López-Camarillo C; Ruíz-García E; Salinas-Vera YM; Silva-Cázares MB; Hernández-de la Cruz ON; Marchat LA; Gallardo-Rincón D
Cells; 2021 Jun; 10(6):. PubMed ID: 34204094
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
Sun Z; Gao S; Xuan L; Liu X
J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1.
Sun T; Yang P; Gao Y
Exp Physiol; 2020 Jan; 105(1):75-87. PubMed ID: 31645082
[TBL] [Abstract][Full Text] [Related]
20. The Role of EMT-Related lncRNAs in Ovarian Cancer.
Lampropoulou DI; Papadimitriou M; Papadimitriou C; Filippou D; Kourlaba G; Aravantinos G; Gazouli M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
